查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球皮膚填充劑市場-2022-2029
市場調查報告書
商品編碼
1146447

全球皮膚填充劑市場-2022-2029

Global Dermal Fillers Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

在預測期間（2022-2029 年），全球真皮填充劑市場規模預計將以 11.10% 的複合年增長率增長。

皮膚填充劑是一種注射劑，在服用時可以撫平面部皺紋並撫平細紋。醫療保健專業人員通常將真皮填充劑注射到眼睛、嘴巴和鼻子附近的區域。這種備受期待的整容程序通常直接產生效果並持續數月至數年。

市場動態

全球皮膚填充劑市場受到技術進步、皮膚填充劑在醫療和美容手術中的使用增加、患者意識提高以及美容手術支出增加的推動。

提高公眾對醫療和美容護理的認識推動市場增長

在預測期內，抗衰老需求的增加和社交媒體意識的提高將推動市場。根據 2022 年 4 月發表在《美容外科雜誌》上的一篇文章，技術的進步和社交媒體的普及提高了人們對各種美容標準和審美結果的認識，最終導致了對美、吸引力和治療目標的定義。傳播。相反，客戶在美容醫學上的支出急劇增加，為未來的美容醫學市場創造了廣闊的前景。

大約 70% 的受訪醫生回答說他們應該在 20 多歲和 30 多歲時接受美容醫學。此外，在美感高的女性中，32%的30多歲女性和37%的40多歲女性回答應該接受治療。

此外，在社交媒體時代，真皮填充劑市場正在發展，以通過平衡面部來吸引年輕一代。這些治療旨在增強和保持年輕，而不是糾正與年齡相關的變化，包括下巴輪廓、豐唇、液體隆鼻和軟糖微笑矯正。

此外，真皮填充劑用於擴大面部以滿足美容的審美概念，滿足特定的曲線、輪廓、尺寸和比例，以擁有傳統迷人的面部。或用於重塑老化的面部，從而使其青春。與永久性外科美容手術相比，使用軟組織可生物降解填充物（一種非永久性注射裝置）進行面部重建是一種經濟實惠且相對安全的手術。

真皮填充劑的副作用阻礙市場增長

但是，注射部位周圍的常見副作用是立竿見影的：發紅、腫脹、疼痛、瘀傷、瘙癢和皮疹。罕見的副作用包括注射部位的填充劑滲漏、肉芽腫、感染、填充劑的炎症反應、注射部位周圍的結節、填充劑從一個部位遷移到另一個部位以及血管損傷增加。這些副作用限制了市場增長。

COVID-19 影響分析

COVID-19 的出現對全球醫療和美容市場產生了相當大的影響。正如 2022 年 9 月發表的文章，整容手術和美容干預更像是一種生活方式的奢侈品，而不是必需品。在 COVID 流行開始時執行的程序數量已顯著減少。

但是，保持社交距離的做法導致人們花更多時間在視頻通話上，從而加劇了對自己外表的不滿，有時還會促使人們對身體，尤其是面部產生異常想法，從而導致： 對美容和美容治療的需求增加。

另一方面，與 SARS-CoV-2 感染相關的疫苗會導致過去接受過美容或美容手術的人出現皮膚反應。此外，在災難或危機之後，對改善身心自我接納的需求通常會增加，COVID-19 也不例外。

截至 2022 年，它已從 COVID-19 中恢復過來，幾乎所有人都可以使用醫療保健和美容設施，它正在推動全球市場。

細分分析

透明質酸 (HA) 細分市場預計將在預測期間（2022-2029 年）以最快的複合年增長率增長。

透明質酸 (HA) 細分市場佔有最大的市場份額。可注射 HA 填充劑的普及使它們上升到時尚的地位。它導致以前罕見的異位血管閉塞性損傷的發生率隨之增加，從面部皮膚壞死到神經眼科後遺症。

根據發表在 Molecules 2022 上的一篇文章，自 2005 年至 2020 年 HA 注射凝膠的銷量飆升 700% 以來，真皮填充劑的受歡迎程度已達 20 年。截至 2022 年，全球化妝品填充劑市場預測到 2030 年將達到 65%。

化學交聯透明質酸（HA，透明質酸）凝膠衍生物的出現，為外科、再生醫學和藥理學帶來了新的治療應用，標誌著生物醫學領域的新紀元。然而，近年來最顯著的增長可能是在美容醫學中使用基於水膠體 HA 的真皮填充劑。這些可注射 HA 凝膠的爆炸性使用導致由於意外血管內註射凝膠體積而導致輕微缺血性組織梗塞的發生率隨之增加，從而導致填充物阻塞血管。

區域分析

北美在全球真皮填充劑市場佔有最大的市場份額

北美在真皮填充劑市場上占主導地位，預計在預測期內將顯示出類似的趨勢。市場受到先進醫療基礎設施等因素的推動。這是由於醫療和美容意識的提高、該地區主要參與者的活動以及該地區產品的現成供應。

根據發表在 Molecules 2022 上的一篇文章，僅在美國每年就進行大約 340 萬次皮膚填充程序，其中大約 80% 的填充劑產品由 HA 填充劑組成。對美容注射劑的這種不斷增長的需求是由於所有年齡和性別群體對整形手術的接受程度越來越高，獲得和營銷的改善，以及產品成本的降低，促進了進一步的採用。我們正在創造一個似乎是競爭激烈的市場。

此外，市場參與者正在採用合作和產品發布等市場策略來擴展業務。例如，2020 年 5 月，艾伯維（AbbVie）收購艾爾建（Allergan）以擴大業務。艾爾建擁有一系列品牌和一流產品，主要專注於四大治療領域：醫學美容、眼部護理、中樞神經系統和胃腸系統。

競爭格局

真皮填充劑市場是一個來自本地和全球參與者的適度競爭市場。為市場增長做出貢獻的主要公司包括 Allergan plc、Galderma、Merz Pharma、Sinclair Pharma plc、AQTIS Medical、Teoxane Laboratories、Cytophil Inc、Cynosure、Dr. Korman Laboratories Ltd.，而 Advanced Aesthetic Technologies Inc. 是主要參與者採用了多種增長戰略，例如產品發布、收購和合作夥伴關係，為真皮填充劑市場的全球增長做出了貢獻。

產品組合

JUVEDERM：JUVEDERM 系列透明質酸真皮填充劑可修復中度至重度面部皺紋和褶皺。

全球皮膚填充劑市場報告將提供對大約 40 多個市場數據表、45 多個圖表和 200 頁（大約）的訪問。

內容

第 1 章市場研究方法和範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因素
    • 促進因素
      • 越來越重視美學
      • 對非手術面部矯正手術的需求
    • 抑制因素
      • 市場上假冒商品流通量增加
    • 商機
    • 影響分析

第 5 章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品類型

  • 可吸收真皮填充劑
  • 非吸收性真皮填充劑

第 8 章按材料分類

  • 透明質酸 (HA)
  • 聚乳酸 (PLA)
  • 羥基磷灰石鈣 (CaH)
  • 聚甲基丙烯酸甲酯 (PMMA)
  • 膠原蛋白
  • 其他

第 9 章按應用程序

  • 面部線條矯正治療
  • 撕掉
  • 疤痕治療
  • 其他

第 10 章最終用戶

  • 醫院
  • 門診手術中心
  • 皮膚科診所
  • 其他

第 11 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 12 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 按類型進行基準測試

第 13 章公司簡介

  • Allergan plc
    • 公司簡介
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Galderma
  • Merz Pharma
  • Sinclair Pharma plc.
  • AQTIS Medical
  • Teoxane Laboratories
  • Cytophil Inc.
  • Cynosure
  • Dr. Korman Laboratories Ltd.
  • Advanced Aesthetic Technologies Inc.

第 14 章全球皮膚填充劑市場-DataM

簡介目錄
Product Code: DMPH1119

Market Overview

The global dermal fillers market size was growing at a CAGR of 11.10% during the forecast period (2022-2029).

Dermal fillers are injections that will plump up wrinkles and smooth lines on the face after taking it. Healthcare professionals generally inject dermal fillers in the areas near the eyes, mouth and nose. This expected cosmetic procedure typically delivers results directly and lasts months or years.

Market Dynamics

The global dermal fillers market is driven by technological advancements, the growing adoption of dermal fillers in medical aesthetics surgeries, improving patient awareness, and rising expenditure on cosmetic procedures.

Increasing awareness of medical aesthetics procedures in public drives market growth

The rising demand for anti-aging and increasing social media awareness drive the market in the forecast period. As per the article published in the Aesthetic Surgery Journal in April 2022, technological advances and widespread use of social media have increased awareness of diverse standards of beauty and aesthetic outcomes, ultimately broadening definitions of beauty and attractiveness and the consciousness of treatment goals. This dramatic rise in customer spending on cosmetic procedures has, in turn, generated promising prospects for the aesthetic medicine market in the future.

Approximately 70% of surveyed physicians indicated that their patients should seek aesthetic treatments in their 20s and 30s. Among aesthetically conscious female survey respondents, 32% indicated that they should seek treatment in their 30s, and 37% reported that they should seek treatment in their 40s.

In addition, in the era of social media, the dermal fillers market has developed to include a younger demographic with facial re-balancing. These treatments, aimed at the enhancement and preservation of youth rather than correcting age-related changes, include chin augmentation, lip plumping, liquid rhinoplasty, and gummy smile modification.

Moreover, dermal fillers are deployed to increase the face to meet the aesthetic concept of beauty, dictating that certain curves, contours, dimensions, and ratios are fulfilled to have a conventionally attractive face or to reform volumetric dimensions and hence youth in the aging face. Facial regeneration using soft tissue biodegradable fillers, a non-permanent injectable device, provides an affordable and relatively safe procedure compared to permanent surgical cosmetic procedures.

The side effects of dermal fillers will hamper the growth of the market

However, the side effects which tend to occur around the injection site can be immediate, including redness, swelling, pain, bruising, itching and rash. Rare side effects include leakage of the filler through the injection site, granulomas, infection, inflammatory reaction to the filler, nodules around the injection site, movement of the filler from one area to another, and injury to blood vessels. These side effects limit the market growth.

COVID-19 Impact Analysis

The appearance of COVID-19 considerably impacted the global medical aesthetics market. As per the article published in September 2022, cosmetic procedures and esthetic interventions are some luxurious lifestyles rather than a necessity. There has been a substantial reduction in procedures performed at the beginning of the COVID pandemic.

However, social distancing has led people to spend long hours on video calls, which promoted appearance dissatisfaction and sometimes evolution of dysmorphic thoughts about the body, especially the face; this has resulted in increased demand for esthetic and cosmetic procedures.

On the other hand, the SARS-CoV-2 infection and associated vaccines have given rise to several dermatologic reactions in those individuals who have previously undergone cosmetic surgery or esthetic interventions. Moreover, the demand for improving physical and mental self-acceptance usually increases after any disaster or crisis, and COVID-19 is no exception.

As of 2022, the market is recovering from COVID-19, and almost all people can access healthcare and cosmetic facilities, which drives the market worldwide.

Segment Analysis

The Hyaluronic Acid (HA) segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The Hyaluronic Acid (HA) segment accounts for the largest market share. The popularity surge of injectable HA fillers has risen to in-vogue status. It has brought a concomitant gain in the incidence of once-rare iatrogenic vaso-occlusive injuries, from disfiguring facial skin necrosis to disabling neuro-ophthalmological sequelae.

As per the article published in Molecules 2022, dermal fillers have witnessed a surge in popularity in the two decades since HA injectable gels sales boomed by 700% between 2005 and 2020. As of 2022, the global market for cosmetic fillers registered a forecast of 65% by 2030.

The advent of chemically cross-linked hyaluronic acid (HA, hyaluronan) gel derivatives has indicated a new era in the biomedical arena, yielding novel therapeutic applications in surgery and regenerative medicine, and pharmacology. However, it is perhaps the utilization of hydro colloidal HA-based dermal fillers in aesthetic medicine that has witnessed the most significant growth in the last years. The explosion in the use of these injectable HA gels has brought a simultaneous rise in the incidence of subtle ischemic tissue infarcts stemming from the accidental intravascular injection of gel boluses, resulting in filler-induced vascular occlusion.

Geographical Analysis

North America region holds the largest market share of the global dermal fillers market

North America dominates the market for dermal fillers and is anticipated to show a similar trend over the forecast period. The market is driven by factors such as advanced healthcare infrastructure. The increasing awareness of medical aesthetics procedures, active regional key players, and easy availability of products in the region.

As per the article published in Molecules 2022, in the United States alone, approximately 3.4 million dermal filler procedures are performed yearly, with HA fillers comprising nearly 80% of filler products. This increased demand for cosmetic injectables stems from the growing acceptance of plastic surgery procedures across all age and gender groups, increased accessibility and marketing, and decreased cost of products, creating an increasingly competitive market likely to favor further adoption.

In addition, the market players are adopting the market strategies such as collaboration and product launches to expand their business. For instance, in May 2020, AbbVie acquired Allergan to expand its business. Allergan has a portfolio of brands and best-class products mainly focused on four key therapeutic areas: medical aesthetics, eye care, central nervous system and gastroenterology.

Competitive Landscape

The dermal fillers market is a moderately competitive presence of local and global companies. Some of the key players contributing to the market's growth are Allergan plc, Galderma, Merz Pharma, Sinclair Pharma plc, AQTIS Medical, Teoxane Laboratories, Cytophil Inc., Cynosure, Dr. Korman Laboratories Ltd., and Advanced Aesthetic Technologies Inc., among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, contributing to the growth of the dermal fillers market globally.

For instance,

  • In January 2020, Anika Therapeutics, Inc., a global, integrated joint conservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid technology platform, agreed to acquire Parcus Medical, a leading, privately-held sports medicine company, and Arthrosurface, a leading, privately-held provider of the joint surface and preservation solutions for active patients.

Allergan plc

Overview:

Allergan (part of Abbevie) is an American pharmaceutical company founded in 2013, and it produces products through advanced research to develop next-generation neuromodulator therapies and other treatments for neurological conditions.

Product Portfolio:

JUVEDERM: The JUVEDERM family of hyaluronic acid dermal fillers corrects moderate to severe facial wrinkles and folds.

The global dermal fillers market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing focus on aesthetics
      • 4.1.1.2. Demand for non-surgical procedures for facial correction
    • 4.1.2. Restraints:
      • 4.1.2.1. Growing circulation of counterfeit products in the market
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Absorbable Dermal Fillers*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Non-Absorbable Dermal Fillers

8. By Material

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 8.1.2. Market Attractiveness Index, By Material
  • 8.2. Hyaluronic Acid (HA)*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Poly-L-Lactic Acid (PLA)
  • 8.4. Calcium Hydroxylapatite (CaH)
  • 8.5. Polymethylmethacrylate (PMMA)
  • 8.6. Collagen
  • 8.7. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Facial Line Correction Treatment*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Lip Enhancement
  • 9.4. Scar Treatment
  • 9.5. Others

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Ambulatory Surgical Centers
  • 10.4. Dermatology Clinics
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Type Benchmarking

13. Company Profiles

  • 13.1. Allergan plc*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Galderma
  • 13.3. Merz Pharma
  • 13.4. Sinclair Pharma plc.
  • 13.5. AQTIS Medical
  • 13.6. Teoxane Laboratories
  • 13.7. Cytophil Inc.
  • 13.8. Cynosure
  • 13.9. Dr. Korman Laboratories Ltd.
  • 13.10. Advanced Aesthetic Technologies Inc.

LIST NOT EXHAUSTIVE

14. Global Dermal Fillers Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us